These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33230916)

  • 1. Recent advances in smooth muscle tumors with PGR and PLAG1 gene fusions and myofibroblastic uterine neoplasms.
    Chiang S
    Genes Chromosomes Cancer; 2021 Mar; 60(3):138-146. PubMed ID: 33230916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features.
    Chiang S; Samore W; Zhang L; Sung YS; Turashvili G; Murali R; Soslow RA; Hensley ML; Swanson D; Dickson BC; Stewart CJR; Oliva E; Antonescu CR
    Am J Surg Pathol; 2019 Jun; 43(6):810-818. PubMed ID: 30829727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors.
    Arias-Stella JA; Benayed R; Oliva E; Young RH; Hoang LN; Lee CH; Jungbluth AA; Frosina D; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
    Am J Surg Pathol; 2019 Mar; 43(3):382-388. PubMed ID: 30489320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the Spectrum of NR4A3 Fusion-Positive Gynecologic Leiomyosarcomas.
    Momeni-Boroujeni A; Mullaney K; DiNapoli SE; Leitao MM; Hensley ML; Katabi N; Allison DHR; Park KJ; Antonescu CR; Chiang S
    Mod Pathol; 2024 May; 37(5):100474. PubMed ID: 38508521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLAG1-rearrangment in a uterine leiomyosarcoma with myxoid stroma and heterologous differentiation.
    Thiryayi SA; Turashvili G; Latta EK; Swanson D; Zhang L; Antonescu CR; Dickson BC
    Genes Chromosomes Cancer; 2021 Oct; 60(10):713-717. PubMed ID: 34184333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelioid leiomyosarcoma of broad ligament harboring PGR-NR4A3 and UBR5-PGR gene fusions: a unique case report.
    Ren H; Li Y; Yao Q; Lv H; Tang S; Zhou X; Yang W
    Virchows Arch; 2022 Apr; 480(4):933-938. PubMed ID: 34351486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxoid smooth muscle neoplasia of the uterus: comprehensive analysis by next-generation sequencing and nucleic acid hybridization.
    Yoon JY; Mariño-Enriquez A; Stickle N; de Borja RJ; Ismiil N; Djordjevic B; Virtanen C; Ravat A; Nucci MR; Mirkovic J; Parra-Herran C
    Mod Pathol; 2019 Nov; 32(11):1688-1697. PubMed ID: 31189997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical and selected genetic reflex testing of all uterine leiomyosarcomas and STUMPs for ALK gene rearrangement may provide an effective screening tool in identifying uterine ALK-rearranged mesenchymal tumors.
    Ptáková N; Miesbauerová M; Kosťun J; Grossmann P; Šidlová H; Pavelka J; Presl J; Alaghehbandan R; Bouda J; Ondič O
    Virchows Arch; 2018 Nov; 473(5):583-590. PubMed ID: 30116888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine mesenchymal tumours: recent advances.
    Momeni-Boroujeni A; Chiang S
    Histopathology; 2020 Jan; 76(1):64-75. PubMed ID: 31846533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
    Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
    Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1.
    Haimes JD; Stewart CJR; Kudlow BA; Culver BP; Meng B; Koay E; Whitehouse A; Cope N; Lee JC; Ng T; McCluggage WG; Lee CH
    Am J Surg Pathol; 2017 Jun; 41(6):773-780. PubMed ID: 28490045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing.
    Mas A; Alonso R; Garrido-Gómez T; Escorcia P; Montero B; Jiménez-Almazán J; Martín J; Pellicer N; Monleón J; Simón C
    Am J Obstet Gynecol; 2019 Oct; 221(4):320.e1-320.e23. PubMed ID: 31121144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases.
    Lopez-Nunez O; John I; Panasiti RN; Ranganathan S; Santoro L; Grélaud D; Wu T; Buccoliero AM; Casanova M; Alaggio R; Surrey LF
    Mod Pathol; 2020 Apr; 33(4):576-590. PubMed ID: 31690781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 Expression and Tumor-infiltrating Lymphocytes in Uterine Smooth Muscle Tumors: Implications for Immunotherapy.
    Shanes ED; Friedman LA; Mills AM
    Am J Surg Pathol; 2019 Jun; 43(6):792-801. PubMed ID: 31009388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Uterine Mesenchymal Neoplasms.
    Kertowidjojo EC; Bennett JA
    Surg Pathol Clin; 2022 Jun; 15(2):315-340. PubMed ID: 35715164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLAG1-Rearranged Uterine Sarcomas: A Study of 11 Cases Showing a Wide Phenotypical Spectrum Not Limited to Myxoid Leiomyosarcoma-like Morphology.
    Michal M; Agaimy A; Croce S; Mechtersheimer G; Gross JM; Xing D; Bell DA; Gupta S; Mosaieby E; Martínek P; Klubíčková N; Michalová K; Bouda J; Fínek J; Hernandez T; Michal M; Schoolmeester JK; Ondič O
    Mod Pathol; 2024 Jun; 37(9):100552. PubMed ID: 38942115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change.
    Shintaku M; Fukushima A
    Pathol Int; 2006 Oct; 56(10):625-8. PubMed ID: 16984620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course.
    Parra-Herran C; Quick CM; Howitt BE; Dal Cin P; Quade BJ; Nucci MR
    Am J Surg Pathol; 2015 Feb; 39(2):157-68. PubMed ID: 25321329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors.
    Fadare O; Liang SX
    Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine inflammatory myofibroblastic tumor harboring novel NUDCD3-ROS1 and NRP2-ALK fusions: clinicopathologic features of 4 cases and literature review.
    Zhang L; Luan L; Shen L; Xue R; Huang J; Su J; Huang Y; Xu Y; Wang X; Shao Y; Ji Y; Xu C; Hou Y
    Virchows Arch; 2023 Mar; 482(3):567-580. PubMed ID: 36624188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.